cbdMD, Inc. (YCBD)

0.4144 -0.0318 (-7.13%) At close: 04:00PM EDT

cbdMD, Inc.

8845 Red Oak Boulevard
Charlotte, NC 28217
United States
704 445 3060
https://www.cbdmd.com

Sector(s): Healthcare
Industry: Drug Manufacturers—Specialty & Generic
Full Time Employees: 154

Key Executives

Name	Title	Pay	Exercised	Year Born
Mr. Martin A. Sumichrast	Chairman & Co-CEO	590.18k	N/A	1967
Mr. Raymond Scott Coffman	Co-Founder, Pres, Co-CEO & Director	563.29k	N/A	1962
Mr. T. Ronan Kennedy	CFO, COO, Sec. & Treasurer	247.12k	N/A	1980
Mr. John Weston	Director of Investor Relations	N/A	N/A	N/A
Mr. Lance Blundell	Gen. Counsel	N/A	N/A	1971
Robert Pettway	Director of PR	N/A	N/A	N/A
Mr. Francisco Mangual	Sr. VP of Sales	N/A	N/A	1979
Mr. Matthew Coapman	Chief Marketing Officer	N/A	N/A	1976
Dr. Sibyl Swift Ph.D.	VP for Scientific & Regulatory Affairs	N/A	N/A	1981
Mr. David Johnson	Sr. VP of Bus. Devel.	N/A	N/A	1970

Amounts are as of December 31, 2021 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

cbdMD, Inc. produces and distributes various cannabidiol (CBD) products. The company owns and operates consumer hemp-based CBD brands, such as cbdMD, Paw CBD, and cbdMD Botanicals. Its cbdMD brand products include CDB tinctures, gummies, topicals, capsules, bath bombs, bath salts, and sleep aids. It also offers veterinarian-formulated products, including tinctures, chews, and topicals under the Paw CBD brand name. The company distributes its products through its e-commerce Website, third-party e-commerce sites, wholesalers, and various brick and mortar retailers in the United States. It has a research partnership with the University of Mississippi to identify novel cannabinoids. The company was formerly known as Level Brands, Inc. and changed its name to cbdMD, Inc. in May 2019. cbdMD, Inc. was incorporated in 2015 and is headquartered in Charlotte, North Carolina.

Corporate Governance

cbdMD, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.